ArticleHormones & cancer2016

CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy.

Huiying Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.